Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Container Labels Expose Two Sides Of Color: Attention Getter, Lure To Medication Errors

Executive Summary

FDA draft guidance lays out how sponsors can design drug container labels and carton labeling to avoid drug use mistakes by making the most important information accessible to health care providers and patients.

You may also be interested in...



Pharmacy Metric Dispensing: Is Compliance Possible Without Mandates?

Backed by FDA and CDC, the National Council for Prescription Drug Programs is calling on the pharmacy industry to use milliliter (mL) as the standard unit of measure for oral liquid medicines rather than the commonly used teaspoon and tablespoon in order to eliminate dosing errors.

Medication Errors Could Be Reduced By Randomly Assigning NDC Numbers, FDA Says

National drug codes should be dissimilar to avoid mistakes by health care providers when they verify they have the right drug, strength and formulation for their patient, FDA says in draft guidance on designing drug container labels and carton labeling.

Roxane's Redesigned Morphine Carton Reflects Orderly Rollout After Safety Concern

FDA allows existing stock to be used up over the course of a year after the new color-coded container for the high-potency product was approved.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel